GRDN vs SGRY
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
GRDN · Guardian Pharmacy Services$46.94 ▲ 0.58%
SGRY · Surgery Partners$26.78 ▲ 0.34%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- GRDN +63.7%
- SGRY +64.4%
Head to head
| Metric | GRDN | SGRY |
|---|---|---|
| Price | $46.94 | $26.78 |
| Change today | ▲ 0.58% | ▲ 0.34% |
| Market cap | $2.97B | $3.50B |
| Return, 3 months | +24.5% | +92.0% |
| Return, year to date | +56.0% | +73.3% |
| Return, 1 year | +65.5% | +69.1% |
| P/E (TTM) | 40.1 | – |
| P/B | 11.1 | 2.1 |
| P/E percentile vs own 5y | 58th | 54th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -1.7% | -0.8% |
| Net profit growth (YoY) | +99.3% | -44.3% |
| Gross margin | 22.4% | 22.2% |
| Operating margin | 6.5% | 12.9% |
| Net margin | 5.1% | -2.6% |
| Return on equity | 33.2% | -5.1% |
| Analyst target vs. price | +4.4% | -22.9% |
| Analyst buy share | 100% | 14% |
| RSI (14) | 57 | 84 |
| 30-day volatility | 55.1% | 118.1% |
| Max drawdown, 1 year | -18.8% | -34.0% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SGRY is the largest of the group by market value.
- SGRY has returned the most over the past year.
- SGRY is growing revenue fastest.
- GRDN keeps the most profit per dollar of sales.
- GRDN has been the calmest stock over the last 30 days.